The Effect of Ketorolac on Posterior Minimally Invasive Transforaminal Lumbar Interbody Fusion: an interim analysis from a randomized, double-blinded, placebo-controlled trial

: Postoperative pain control following posterior lumbar fusion continues to be challenging and often requires high doses of opioids for pain relief. The use of ketorolac in spinal fusion is limited due to the risk of pseudarthrosis. However, recent literature suggests it may not affect fusion rates with short-term use and low doses.

Source: The Spine Journal - September 7, 2021 Category: Orthopaedics Authors: Chad F Claus, Evan Lytle, Michael Lawless, Doris Tong, Diana Sigler, Lucas Garmo, Dejan Slavnic, Jacob Jasinski, Robert W McCabe, Ascher Kaufmann, Gustavo Anton, Elise Yoon, Ammar Alsalahi, Karl Kado, Peter Bono, Daniel A Carr, Prashant Kelkar, Clifford H Source Type: research